Search results
FDA advisory committee says risks of Novo Nordisk’s once-weekly insulin outweigh benefits in type 1 ...
Endpoints News· 23 hours agoAn FDA advisory committee on Friday voted not to recommend Novo Nordisk’s once-weekly insulin...
AdventHealth study aims to increase type 1 diabetes screening
Orlando Sentinel via Yahoo News· 5 days agoAdventHealth researchers are seeking local participants for a study that will attempt to identify people with type 1 diabetes early in ...
Isabelle Stombres, who has Type 1 diabetes, hits first career home run for Kaneland. ‘I just knew it...
Chicago Tribune· 3 days agoSay this about Kaneland’s Isabelle Stombres. Stombres was diagnosed with Type 1 diabetes in seventh...
US FDA panel votes against Novo Nordisk's weekly insulin in type 1 diabetes patients
AOL· 23 hours agoNovo is aiming to be the first to hit the market with a weekly insulin product, offering an alternative for patients with type 1 and type 2 diabetes who now depend on multiple daily injections ...
EXCLUSIVE: Local teen among first to receive groundbreaking diabetes treatment
WRBL Columbus via Yahoo News· 2 days agoCOLUMBUS, Ga. (WRBL) — One of the first patients in the world to be treated by a new drug is getting...
Supreme Court Justice Sonia Sotomayor says she cries after some decisions
Fox News· 3 hours agoLiberal Supreme Court Justice Sonia Sotomayor has revealed that she is sometimes brought to tears in...
New biomarkers found to predict kidney failure in type 1 diabetes patients
Medical Xpress· 3 days agoBy performing the first epigenome-wide association analysis in patients with diabetic kidney...
US FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin
Reuters via AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration's staff said on Wednesday the use of Novo Nordisk's...
FDA advisers weigh benefits of weekly insulin for people with diabetes
CNN via Yahoo News· 23 hours agoMost types of insulin therapy, an important part of diabetes treatment for many people, are given as...
JDRF-Authored Paper Shows Pathway to Accelerate Disease-Modifying Therapies for People with Type 1 ...
KOLR - KSFX Ozarks· 5 days agoThe paper, written by JDRF Vice President of Research Esther Latres, Ph.D., and co-authored by JDRF staff and other leaders in the field, reviewed...